Frontiers in Molecular BiosciencesCancer BiologyPeer-reviewed journal article
Metabolic readouts of tumor instructed normal tissues (TINT) identify aggressive prostate cancer subgroups for tailored therapy
Ilona DudkaiD, João FigueiraiD, Pernilla WikströmiD, Anders R. J. BerghiD, Gerhard GröbneriD
- Citations
- 2
- FWCI
- 0.48
- Field percentile
- top 48%
Abstract
BackgroundProstate cancer (PC) diagnosis relies on histopathological examination of prostate biopsies, which is restricted by insufficient sampling of all tumors present. Including samples from non-PC but tumor instructed normal tissues (TINT) may increase the diagnostic power by exploring the adaptive responses in benign tissues near tumors. MethodsHere, we applied high-resolution magic angle spinning nuclear magnetic resonance (HR MAS NMR) to identify metabolomic biomarkers with high diagnostic value in benign prostate tissues near low/high-grade tumors. ResultsBenign samples near high-grade tumors (B ISUP 3+4) exhibit altered metabolic profiles compared to those close to low-grade tumors (B ISUP 1+2). The levels of six metabolites were significantly different between the two groups; myo-inositol, lysine, serine and combined signal of lysine/leucine/arginine were increased in benign samples near high-grade tumors (B ISUP 3+4) compared to near low-grade tumors (B ISUP 1+2), while levels of ethanolamine and lactate decreased. Additionally, we revealed metabolic differences in non-cancer tissues as a function of their distance to the nearest tumor. Eight metabolites (glutathione, glutamate, combined signal of glutamate/glutamine - glx, glycerol, inosine, ethanolamine, serine and arginine) significantly differentiated between benign tissue located close to the tumor (d [≤] 5 mm) compared to those far away (d [≥] 1 cm). ConclusionsOur HR MAS NMR-based approach identified metabolic signatures in prostate biopsies that reflect the response of benign tissues to the presence of nearby located tumors in the same prostate and confirmed the power of the TINT concept for improved PC diagnostics and understanding of tumor-tissue interactions.
- organism: human
- assay: metabolomics
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Metabolic deregulation in prostate cancer
Sriganesh Srihari, Ray Kwong, … Elliot Smith·Molecular OmicsPeer-reviewed·Sep 6, 2018
- Molecular analysis of prostate cancer: prostate tissue and urine proteomics based approach
- Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery
B. Lee, I. Mahmud, … R. J. Perera·bioRxiv·Apr 4, 2019
- Ultrastructural analysis of prostate cancer tissue provides insights into androgen-dependent adaptations to membrane contact site establishment
L. M. Butler, E. Evergren·bioRxiv·May 10, 2023
- Deep phenotyping of the prostate tumor microenvironment reveals molecular stratifiers of relapse and links inflammatory chemokine expression to aberrant metabolism
Sebastian Krossa, Maria K. Andersen, … May‐Britt Tessem·Nature CommunicationsPeer-reviewed·Nov 19, 2025
- Differential expression of proteins in human prostate cancer tissues probed by MALDI imaging mass spectrometry
A. Mitra, S. K. Choubey, … A. Mandal·bioRxiv·Oct 5, 2020